237 results
Page 10 of 12
424B5
d0a9ef
4 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
kjb0ez3ohi iptvgghr
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.2
avcuzi 9sm75
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.3
s2aay5hq 23cm9w6u8t
3 Mar 14
Current report (foreign)
12:00am
424B5
do8xvjldh21muxun
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99
bzhogo3uq p4naq
24 Feb 14
BioLineRx Appoints Dr. Sandra Panem to
12:00am
6-K
EX-99
5ufs0kk
23 Jan 14
BioLineRx Receives Orphan Drug
12:00am
6-K
EX-99
s64yo 66n
21 Jan 14
BioLineRx Receives Approval to Commence
12:00am
6-K
EX-99
ah97c4bstivhn
13 Jan 14
Current report (foreign)
12:00am
6-K
EX-99
nl9xdu0 o6scmve
8 Jan 14
Current report (foreign)
12:00am
6-K
EX-99
h8ry2a
18 Dec 13
Current report (foreign)
12:00am
6-K
EX-99
w8kj2aco45fx
16 Dec 13
BioLineRx Announces Promising Initial Phase 2
12:00am
6-K
EX-99
qy2hk3s6
10 Dec 13
BioLineRx Presents Positive Preclinical Results of
12:00am
6-K
EX-99
ls16272p8whgdad0xru
26 Nov 13
Current report (foreign)
12:00am
6-K
EX-99
m7bv2mrv4z lqkxu0
19 Nov 13
BioLineRx Reports Publication in Peer Review Journal
12:00am
6-K
EX-99
866peztfollefg 1lxx
4 Nov 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
6-K
EX-99
s0tbke0 t0dc9xdthl
23 Oct 13
Current report (foreign)
12:00am
6-K
EX-99
9ut4rl
7 Oct 13
BioLineRx Announces Receipt of Notice of Allowance
12:00am
6-K
EX-99
21pq1h7ryvkgbildo7es
24 Sep 13
BioLineRx Announces Regulatory Submission for Phase
12:00am
6-K
EX-99
jhn86
17 Sep 13
BioLineRx Announces Receipt of a Notice of Allowance
12:00am